Differential Response to Medical Therapy for Male Lower Urinary Tract Symptoms

被引:5
|
作者
Bechis S.K. [1 ]
Kim M.M. [1 ]
Wintner A. [1 ]
Kreydin E.I. [1 ]
机构
[1] Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
关键词
Benign prostatic hyperplasia; Lower urinary tract symptoms; Medical therapy; Personalized medicine; Risk stratification;
D O I
10.1007/s11884-015-0295-6
中图分类号
学科分类号
摘要
Medical therapy has assumed a critical role in the treatment of male lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction. Targeting both bladder and prostate, these medications provide an effective means to manage LUTS for millions of men. However, significant proportion of men do not respond adequately to medical therapy and go on to surgical treatment of bladder outlet obstruction. In order to provide patients with appropriate therapy, prevent unnecessary exposure to drug side effects, and reduce medical costs, it is important to identify those men in whom medication will not be effective. In this review, we focus on the risk factors that predict failure of the common medical therapies for male LUTS. In addition, we describe recently discovered molecular targets that show promise for treatment of LUTS recalcitrant to conventional therapies. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:177 / 185
页数:8
相关论文
共 50 条
  • [1] Medical therapy of lower urinary tract symptoms
    Strittmatter, F.
    Madersbacher, S.
    Stief, C. G.
    Gratzke, C.
    UROLOGE, 2012, 51 (08): : 1125 - 1134
  • [2] An algorithm for medical management in male lower urinary tract symptoms
    Djavan, Bob
    Margreiter, Markus
    Dianat, Seyed Saeid
    CURRENT OPINION IN UROLOGY, 2011, 21 (01) : 5 - 12
  • [3] Male Lower Urinary Tract Symptoms
    Doran, Todd J.
    PHYSICIAN ASSISTANT CLINICS, 2018, 3 (01) : 83 - +
  • [4] Future Pharmacotherapies for Male Lower Urinary Tract Symptoms
    Soler R.
    Neto J.F.N.
    Füllhase C.
    Simonetti R.
    Current Bladder Dysfunction Reports, 2014, 9 (2) : 134 - 141
  • [5] Metabolic syndrome and male lower urinary tract symptoms
    Ineichen, Gallus B.
    Burkhard, Fiona C.
    PANMINERVA MEDICA, 2022, 64 (03) : 329 - 336
  • [6] Clinical guideline for male lower urinary tract symptoms
    Homma, Yukio
    Araki, Isao
    Igawa, Yasuhiko
    Ozono, Seiichiro
    Gotoh, Momokazu
    Yamanishi, Tomonori
    Yokoyama, Osamu
    Yoshida, Masaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (10) : 775 - 790
  • [7] Botulinum neurotoxin A for male lower urinary tract symptoms
    Chartier-Kastler, Emmanuel
    Mehnert, Ulrich
    Denys, Pierre
    Giuliano, Francois
    CURRENT OPINION IN UROLOGY, 2011, 21 (01) : 13 - 21
  • [8] Urodynamics in Male Lower Urinary Tract Symptoms
    Tunuguntla H.S.G.R.
    Parihar J.
    Current Bladder Dysfunction Reports, 2015, 10 (2) : 125 - 131
  • [9] New concepts for the treatment of male lower urinary tract symptoms
    Fuellhase, Claudius
    Hakenberg, Oliver
    CURRENT OPINION IN UROLOGY, 2015, 25 (01) : 19 - 26
  • [10] New strategies in treating male lower urinary tract symptoms
    Fuellhase, Claudius
    Soler, Roberto
    Gratzke, Christian
    CURRENT OPINION IN UROLOGY, 2014, 24 (01) : 29 - 35